Page 10 - ETH Zurich

Diseases, Conditions, Syndromes

Creating a low-cost ventilator for all

ETH Professor Kristina Shea and her team are busy developing a new ventilator. Their aim is to make it as inexpensive, modular and easy to use as possible—the ideal combination for any country that needs this medical device.

Diseases, Conditions, Syndromes

Research into drugs and vaccines to combat COVID-19

As the world anxiously awaits a remedy for the novel coronavirus, ETH Zurich is also involved in the search for active substances and vaccines. This overview sets out the therapeutic approaches pursued by ETH researchers.

Diseases, Conditions, Syndromes

Cost-effective oxygen concentrators

The new virus is conquering the world. The more people who become infected with Sars-CoV-2, the more cases there will be in which severe illness will occur. In these cases, the virus penetrates the lower respiratory tract, ...

Diseases, Conditions, Syndromes

Lockdown measures are having an impact in spread of COVID-19

The "lockdown light" decreed by the Swiss Federal Council has led to each person infected with Sars-CoV-2 going on to infect only one person on average instead of two or three prior to the lockdown, as calculations by a team ...

Diseases, Conditions, Syndromes

Reducing the risk of infection

"Biology shows us that there are additional ways to reduce the risk of serious coronavirus infections, in addition to hand hygiene and keeping distance," Viola Vogel writes.

Health

Method to predict critical circulatory failure

Patients in a hospital's intensive care unit are kept under close observation: Clinicians continuously monitor their vital signs such as their pulse, blood pressure and blood oxygen saturation. This provides doctors and nurses ...

Diseases, Conditions, Syndromes

Calculating the beginnings of the coronavirus epidemic

Analyses of publicly available genome data provide clues to the beginnings of the coronavirus epidemic in China. Researchers from the Department of Biosystems Science and Engineering at ETH Zurich in Basel used a statistical ...

Medications

New substance prevents vascular calcification

Researchers at ETH Zurich and ETH spin-off Inositec have developed a new substance to prevent vascular calcification, which affects many patients suffering from chronic kidney disease. As their metabolism is impaired, calcium ...

Genetics

Genome editing at the crossroads of scandal and cure

Genetic modification of babies in China one year ago was universally condemned. At the same time, CRISPR treatments are on their way into our clinics. Jacob Corn explains the difference.

page 10 from 20